Nifty shows fatigue, analysts say sell on rise I Top takeaways from RIL AGM I Infy beats Street in Q1

To keep you updated, we send ET Markets Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

DAILY BRIEF Wed, Jul 15, 2020 #Q4Results#Coronavirus#StimulusPackage#ExpertViews#StockRecos SENSEX 36051.81 18.75 NIFTY 50 10618.20 10.85 Gold 49013.00 -246.00 USD/INR 75.14 -0.30

TOP OF THE DAY Nifty forms Shooting Star; a 'sell on rise' The index formed a 'Shooting Star' candle on the daily chart. Analysts said it's a 'sell on rise' market and o... RIL AGM takeaways: 5G push, Google deal, JioMart & more Infy projects FY21 revenue guidance at 0-2%: Key takeaways AGM gave better clarity on RIL's roadmap: Kulkarni Ignore Bank Nifty, invest in broader market: Goldilocks Average investor age has dropped to 30: Zerodha Rs 77,500 cr D-St money manager shows off own portfolio

Top Gainers NSE 2 companies (largecap) appreciated more than 5% Wipro 16.78% Infosys 6.09% More from Gainers Top Losers NSE 1 company (largecap) price decreased more than -5% L&T Fin Holding -5.29% More from Losers 52 Week High NSE 45 companies touched new 52-week high today Suven Pharma 9.18% Tanla Solutions 7.56% More from 52 Week High

AdvertorialCombat climate change and get attractive benefits AdvertorialThe evolution of the BMW roundel and why we #JustCantWait to get back on the roads BMW India is taking steps to ensure its customers can get behind the wheel without a worry.

3 big themes for Covid-hit markets 'Covid, US-China and earnings could spook the markets.' Cos with biggest Q4 losses are under eagle eye in Q1 Wipro is now a re-rating candidate. Here's why LIC, FPIs cut stake in this pharma major

Market moguls Podcast Video Bank, NBFC fund-raising spree giving wrong vibes; time to turn extra-cautious Market Watch: Did RIL blow hurt Nifty or is it structural weakness? Infosys reports 12.4% rise in Q1 net profit to Rs 4,272 crore

RECOMMENDATIONS Abbott India Ltd. Buy Abbott India, target price Rs 17,636: ICICI Securities Buy Alkem Laboratories Ltd. Buy Alkem Labs, target price Rs 2902: ICICI Securities Buy Glenmark Pharmaceuticals Ltd. Buy Glenmark Pharma, target price Rs 490: ICICI Securities Buy Strides Pharma Science Ltd. Buy Strides Pharma, target price Rs 489: ICICI Securities Buy Sun Pharmaceutical Industries Ltd. Buy Sun Pharma, target price Rs 585: ICICI Securities Buy

ICICI Pru AMC picks 11 Nifty stocks And ICICI Prudential Asset Management Company, India's third-biggest mutual fund house, played safe in June an... Market Movers: 130 stocks flash sell signals F&O: VIX falls to signal no major decline Market experts say Jio can be Rs 10L cr co in 2 yrs

Quick Links Markets Live | Market Stats | IPOs | Technicals | Commodities | Forex

Follow Us: Download ET Markets App:

About us|Advertise with us|Feedback|Sitemap|Code of Ethics More Newsletters: Daily Newsletter | Markets Morning | ET Investment Opportunities | Wealth | View all © Times Internet Limited. To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here, To unsubscribe or edit your subscriptions please click here